Cite

HARVARD Citation

    Prebet, T. et al. (2022). A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemia. Leukemia & lymphoma. 63 (9), pp. 2180-2188. [Online]. 
  
Back to record